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Abstract 
 
Introduction 
 
Identifying phenotypic manifestations of genetic risk for bipolar disorder (BD) in 
childhood could increase our understanding of aetiological mechanisms.  
 
Aims 
 
To examine whether BD genetic risk is associated with childhood (age 8 years) 
cognitive function. 
 
Methods 
 
Using data from the Avon Longitudinal Study of Parents and Children, we examined 
associations between polygenic risk scores for BD (BD-PRS) derived using 
Psychiatric Genomics Consortium summary data at p-thresholds (PT) 0.01 (primary) 
and 0.5 (secondary) and several cognitive domains (sample sizes 5,613 to 5,936). 
We also examined whether associations were due to SNPs that have shared risk 
effects on schizophrenia (SZ). 
 
 
2 
Results 
 
At PT0.01, the BD-PRS was associated with poorer executive functioning (ß= -0.03, 
95%CI -0.06, -0.01; p=0.013), and, more weakly with poorer processing speed (ß = -
0.02, 95%CI -0.05, 0.02; p=0.075). Evidence of association with both poorer 
processing speed (p=0.016) and performance IQ (p=0.018) was stronger at PT0.5. 
Associations with performance IQ and processing speed were primarily driven by 
genetic effects that are shared with schizophrenia SZ risk, but there was some 
evidence of bipolar-specific genetic effects on childhood executive functioning.  
 
Limitations 
 
The BD-PRS still explains only a small proportion of the variance for BD which will 
have reduced power to detect associations.   
 
Conclusions 
 
Genetic risk for BD manifests as impaired cognition in childhood, and this is driven 
by risk SNPs that are also shared with schizophrenia SZ genetic risk. Further 
elucidation of which cognitive domains are most affected by genetic risk for BD could 
help understanding of aetiology and improve prediction of BD. 
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1. Introduction 
 
Cognitive deficits in childhood have been identified as a possible precursor of BD in 
both familial high-risk and cohort studies (Bora et al., 2017; Bora and Ozerdem, 
2017). However, unlike in schizophrenia (SZ), it is unclear whether deficits are 
present in the premorbid phase of those who eventually go on to develop BD 
(Bortolato et al., 2015; Martino et al., 2015). A number of studies suggest equivocal 
(Kendler et al., 2016; Zammit et al., 2004) or higher cognitive abilities and scholastic 
achievement in those who develop BD compared to controls (Gale et al., 2013; 
MacCabe et al., 2010), whilst others report deficits (Meyer et al., 2004; Sharma et 
al., 2017). It is possible that the relationship between cognitive ability and BD is non-
linear, with increased risk of BD being present both in those with lower, and those 
with higher than average cognitive ability (Kendler et al., 2016). 
 
Approximately 40-60% of adults with BD exhibit cognitive deficits which appear to be 
independent of mood state (Arts et al., 2008; Bora et al., 2009). Several meta-
analyses in adults with BD have found impairments in intelligence quotient (IQ), 
processing speed, working memory, problem solving, verbal learning, visual 
learning, executive functioning, and social cognition (Bora and Ozerdem, 2017; Bora 
et al., 2009; Bortolato et al., 2015).  
 
In contrast to SZschizophrenia (SZ), there is no consensus on the optimal 
assessment of cognition in BD. However, the International society for BD have 
suggested using the Measurement and Treatment Research to Improve Cognition in 
Schizophrenia (MATRICS) consensus cognitive battery (MCCB) (Yatham et al., 
2010) that was developed for assessing cognitive functioning in schizophrenia SZ 
(Marder and Fenton, 2004), and this has now been used by a number of studies 
examining cognition in BD (Bo et al., 2017; Sperry et al., 2015).  
 
Twin, adoption and molecular genetic studies suggest that BD is a highly heritable 
disorder, with heritability estimates ranging between 60-85% (Barnett and Smoller, 
2009). Through genome wide association studies (GWAS), single nucleotide 
polymorphisms (SNPs) occurring more frequently in BD cases relative to controls 
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have been identified (Sklar et al., 2011; Stahl et al., 2018). On an individual level, 
risk SNPs typically have small effects on disease risk. However, by summing trait-
associated alleles across many genetic loci into a polygenic risk score (PRS), a 
greater proportion of genetic variation for BD can be explained (approximately 4% on 
the liability scale in a recent GWAS) (Stahl et al., 2018). Using this approach it is 
then possible to examine the effect of multiple disease-risk SNPs on phenotypes in 
other samples (Cross-Disorder Group of the Psychiatric Genomics, 2013; Purcell et 
al., 2009). 
 
There is a limited understanding of how genetic risk for BD is manifest during 
childhood/adolescence in the general population, as most studies have relied on 
studying relatively small numbers of offspring of adults with BD to characterize 
genetically high-risk individuals (de la Serna et al., 2017; Nurnberger et al., 2011). To 
date, only one study has assessed the associations between a BD-PRS and 
cognitive measures in childhood in the general population. The authors found no 
association between a BD-PRS and social cognition (Coleman et al., 2017).  
 
In this study, we therefore examine whether genetic risk for BD, using a BD-PRS, is 
associated with measures of IQ, processing speed, working memory, problem 
solving, executive function, attention, verbal learning, and emotion recognition during 
childhood in a large general population birth cohort. We also examine the extent to 
which any associations with cognitive deficits are due to risk alleles for BD that 
overlap with SZ given the high genetic correlation between these two disorders 
(Bulik-Sullivan et al., 2015). 
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2. Methods  
 
2.1 Participants 
 
We use data from the Avon Longitudinal Study of Parents and Children (ALSPAC) 
that recruited expectant mothers in the South West of England (Avon) with an 
expected delivery date between 1st April 1991 and 31st December 1992. The initial 
cohort contained 14,062 live births (Boyd et al., 2013; Fraser et al., 2013), and when 
the oldest children were age 7 years, any eligible children who did not join the study 
were invited. The parents and their children have been followed up regularly since 
then (see www.bris.ac.uk/alspac/researchers/data-access/data-dictionary/ for details 
of data collected). Informed consent for the use of data collected via questionnaires 
and clinics was obtained from the participants following the recommendations of the 
ALSPAC Ethics and Law Committee and Local Research Ethics Committees at the 
time (http://www.bristol.ac.uk/alspac/researchers/research-ethics/).  
 
2.2 Cognitive assessments 
 
The cognitive domains we assessed in this study (IQ, processing speed, working 
memory, problem solving, attention, executive function, verbal learning, and social 
cognition) were selected a priori based on the literature of cognitive deficits in people 
with BD. These measures cover most of the domains described in the MCCB, 
although they do not map precisely onto them. All cognitive measures were 
assessed at age 8 years, and all cognitive domain scores were re-coded where 
needed so that higher scores always reflect better cognitive performance. 
 
The Wechsler Intelligence Scale - III (WISC-III) (Wechsler et al., 1992) was used to 
assess the following cognitive domains: 
 
General intelligence: We examined associations with Verbal IQ (VIQ) (derived from 
the information, similarities, arithmetic, vocabulary, comprehension, and forward and 
backward digit span subtests), Performance IQ (PIQ) (derived from the picture 
 
 
6 
completion, picture arrangement, block design, coding and object assembly 
subtests), and Total IQ (TIQ) (VIQ and PIQ combined) scores.  
 
Processing speed: This was assessed using the coding subtest of the WISC-III 
which required the children to place the correct symbol above each number as 
quickly as possible within a set time period.  
 
Working memory: This was assessed using the Freedom From Distractibility index 
score that combined scores from the arithmetic subtest (which required the children 
to solve mathematical problems without the use of pen and paper), and the digit 
span task (which required the children to repeat lists of numbers of increasing length 
in chronological and reverse order).  
 
Problem solving: The block design subtest of the WISC-III was used to assess 
problem solving. The children were required to copy specific patterns of blocks seen 
on a picture and replicate these patterns using real blocks.  
 
Other cognitive domains assessed included: 
 
Executive function: This was assessed using the opposite world’s task from the Test 
of Everyday Attention for Children (TEACh) (Robertson et al., 1996), whereby the 
children were presented with a number (either 1 or 2), and required to verbalise the 
non-presented number as quickly as possible. 
 
Attention: This was assessed using the sky search task from the TEACh. The task 
required the children to distinguish identical from non-identical spaceships and draw 
a circle around only identical spaceships. The score was calculated as the time to 
identify all identical spaceships minus the time taken for the child to circle all pairs 
when only identical pairs were presented.  
 
Verbal learning: This was assessed using the nonword repetition task from the 
Children’s Test of Nonword Repetition (CTNWR) (Gathercole and Adams, 1994). 
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The task required the child to listen to 12 nonsense words and repeat each word 
back. 
   
Emotion recognition: This was assessed using the Diagnostic Analysis of Nonverbal 
Accuracy (DANVA) (Nowicki and Duke, 1994). Children were presented with 24 
faces representing emotions of happiness, sadness, fear or anger, and were 
required to make judgements and verbalise their interpretation of the emotion being 
shown on the screen. As a measure of social cognition, a total emotion errors score 
was derived by summing the errors on each of the emotions. 
 
2.3 Genetic data in ALSPAC 
 
Genetic data from 9,912 participants were obtained using the genome wide single-
nucleotide polymorphism genotyping platform (HumanHap550-Quad; Illumina). 
Following quality control, imputation, and restriction to 1 young person per family, 
genetic data were available on 8,230 individuals (see Supplementary methods 
available online for more detail). Consent for biological samples has been collected 
in accordance with the Human Tissue Act (2004).  
 
Prior to construction of the PRS, single nucleotide polymorphisms (SNPs) were 
removed from the analysis if they had a minor allele frequency (MAF) of <0.01, their 
imputation quality (INFO) score was <0.8, if there was a mismatch of alleles between 
the second PGC-BD GWAS summary statistics and ALSPAC, and if there were any 
palindromic SNPs.  
 
2.4 Construction of the Polygenic Risk Scores (PRS) 
 
Using summary statistics from the second PGC-BD GWAS (20,352 BD cases and 
31,358 controls) (Stahl et al., 2018), second PGC SchizophreniaSZ GWAS (n = 
36,989 cases and 113,075 controls) (Ripke et al., 2014), and the second SZvsBD 
GWAS (20,129 BD cases and 33,426 SZ cases) (Ruderfer et al., 2018), polygenic 
risk scores were created for each individual in ALSPAC.  
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Using PLINK v1.9, SNPs were linkage disequilibrium (LD) clumped using the --clump 
command at r2 <0.2 within 1MB windows. For our primary analyses we derived a 
PRS using SNPs with a PT≤0.01, as this is the threshold which maximally captured 
BD liability in the second PGC-BD GWAS (Stahl et al., 2018). However, as a 
secondary analysis, we also examined associations between a BD-PRS and 
cognitive domains at a less stringent PT≤0.5. 
 
For the schizophreniaSZ  PRS, we retained SNPs with a PT≤0.05, as this is the 
threshold which maximally captures schizophreniaSZ liability (Ripke et al., 2014), 
and for the SZvsBD PRS, we used SNPs with a PT≤0.5 (Ruderfer et al., 2018). 
 
To generate a PRS for each individual in ALSPAC, the --score command in PLINK 
was used. This score is the sum of the total number of risk alleles present for each 
SNP (0, 1, 2) weighted by the log of its odds ratio (OR) for BD from the second PGC-
BD/SZ/SZvsBD GWASs.  
 
2.5 Statistical analysis 
 
Data for all cognitive tasks were standardized, and individuals with scores >3 
standard deviations from the mean were omitted. Linear regression was used to 
determine associations between the BD-PRS and continuous outcomes. These 
results are presented as beta coefficients per standard deviation (SD) increase in 
PRS. The residuals for all outcomes were normally distributed. We tested for 
quadratic effects of the BD-PRS by inclusion of quadratic terms in the models, with 
p-values derived from likelihood ratio tests comparing models with linear and 
quadratic terms to models with linear terms only. As a more explicit test of whether 
both higher and lower genetic risk for BD is associated with cognitive performance, 
we also derived tertiles of the BD-PRS, and compared cognitive performance in 
those with higher/lower BD-PRS compared to the middle (reference category) tertile. 
To help address the issue of multiple testing, we also used a multivariate approach 
in which all cognitive domain outcomes were included in a single model, with a single 
p-value reported that tests the null hypothesis that the associations between the BD-
PRS and cognitive outcomes are equal to 0. 
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For the strongest association(s), we used three approaches to determine the extent 
to which the association between genetic risk for BD and cognitive performance was 
due to risk alleles for BD that are also risk alleles for SZ: 
 
1. First, we used a multivariable model to adjust for the SZ-PRS to determine the 
extent to which the effect of the BD-PRS is due to shared effects with SZ.  
2. Second, we conducted a principal components analysis (PCA) to obtain 2 
orthogonal factors that described: i) shared variance (i.e. what is similar 
genetically) between the BD-PRS and SZ-PRS, and ii) non-shared variance 
(what is genetically different) between the two risk scores. From herein, the 
former will be referred to as the shared component and the latter as the 
difference component. 
3. Third, we used summary statistics from the second PGC GWAS of SZ cases 
vs BD cases to generate a PRS to determine whether common genetic 
variants associated with increased risk of being a SZ case relative to a BD 
case were associated with cognition. From herein, this PRS will be referred to 
as the SZvsBD PRS. 
 
Whilst genetic variation is often associated with geographical and historical 
populations, the ALSPAC sample has been shown to be homogeneous with no 
significant population stratification, and genome-wide analyses of phenotypes 
indicate a low lambda (Martin et al., 2015; Zammit et al., 2014). Therefore, in our 
analyses, we have not adjusted for population stratification using PCA. 
 
Data were analysed using STATA statistical software version 14.1 SE (StataCorp 
LP).  
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3. Results  
 
3.1 Sample characteristics 
 
Of the 8,230 ALSAPC individuals whose genetic data passed quality control checks 
(51.2% male), 6,555 to 7,405 participated in cognitive assessments at age 8 years 
(ST1). Cognitive domains assessed using the WISC-III were the most strongly 
correlated measures (correlations ranged between 0.25 and 0.89), with other 
cognitive domain measures showing weaker correlations (correlations ranged from 
0.08 to 0.38) (see ST2).  
 
Associations between the BD-PRS at both PT’s and cognitive domains are shown in 
Figure 1, ST3 and ST4.  
 
3.2.1 IQ  
 
Using our primary PT≤0.01, there was little or no evidence that higher genetic risk for 
BD was associated with PIQ (p=0.204), VIQ (p=0.922) or TIQ (p=0.485) (ST3). 
However, there was some weak evidence to support quadratic effects of BD-PRS on 
both PIQ (p=0.066) and TIQ (p=0.077), but not for VIQ (p=0.229), indicating that the 
any association is driven primarily in by those at the higher end of the spectrum of 
genetic (ST5).  
 
At the less stringent PT≤0.5, there was evidence that the BD-PRS was associated 
with poorer PIQ (β= -0.03, 95%CI -0.06, -0.01; p=0.018), but not with VIQ (p=0.858) 
or TIQ (p=0.147) (ST4). Similar to the findings at the more stringent PT, there was 
some weak evidence to support quadratic effects of the BD-PRS on both PIQ 
(p=0.063) and TIQ (p=0.075), but not VIQ (p=0.229), again providing evidence that 
the association is primarily driven by those at the higher end of the spectrum of 
genetic risk (ST6).  
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3.2.2 Processing speed 
 
At our primary PT, we found weak evidence of association between the BD-PRS and 
poorer processing speed (ß = -0.02, 95%CI -0.05, 0.02; p=0.075), and no evidence 
of a quadratic effect of the BD-PRS (p=0.961). 
 
There was stronger evidence for an association with processing speed at our 
secondary PT (ß = -0.03, 95%CI -0.04, -0.01; p=0.016), and no good evidence to 
support a quadratic effect of the BD-PRS (p=0.943).  
 
3.2.3 Working memory 
 
We found no evidence of association between higher genetic risk for BD and working 
memory at both our primary (p=0.959) or secondary (p=0.329) PT, and no evidence 
of a quadratic effect at either PT (both p=0.638).  
 
3.2.4 Problem solving 
 
A higher BD-PRS was not associated with problem solving at both the primary 
(p=0.513) and secondary (p=0.570) PT'’s. Similarly, there was no evidence of a 
quadratic at either PT (both p>0.289).  
 
3.3.1 Executive function 
 
The BD-PRS was associated with poorer executive functioning at both PT’s (β= -
0.03, 95%CI -0.06, -0.01; p=0.013) and (β= -0.03, 95%CI -0.06, -0.01; p=0.014) 
(ST4). There was some weak evidence of a quadratic effect of the BD-PRS at both 
primary (p=0.089) and secondary (p=0.083) PT’s.  
 
 
 
 
Formatted: Subscript
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3.3.2 Attention  
 
There was little No evidence of association between the BD-PRS and attention was 
found at either PT (both p>0.115) and no evidence of a quadratic effect at either PT 
(both p>0.466).  
 
3.3 Verbal learning 
 
We found no little evidence of association between the BD-PRS and verbal learning 
at either PT (both p>0.173), or and no evidence of a quadratic effect (both p>0.284).  
 
3.4 Emotion recognition 
 
There was little evidence of No associations were found between the BD-PRS and 
greater number of errors on the total emotion score at either PT (both p>0.134) or in 
recognizing happy, sad, angry or fearful faces (all p>0.116) (ST7),. andThere was 
also no evidence of a quadratic effects (all p>0.758).  
 
3.5 Tertiles of genetic risk and associations with cognitive outcomes  
 
We examined the association between tertiles of genetic risk and our cognitive 
outcomes to help clarify the non-linear patterns of association identified by evidence 
of quadratic effects as described above. Analyses using our primary PT (ST8 and 
SF1), and particularly using our secondary PT, showed evidence that the 
associations between genetic risk for BD and performance IQ, total IQ and executive 
function were driven by those in the highest genetic risk tertile, whilst those in the 
lowest tertile had similar scores on these tasks to those in the middle tertile (ST9 and 
SF2). In contrast, the association with processing speed was observed across the 
whole spectrum of genetic risk, with those in the lowest tertile having better, and 
those in the highest tertile worse, performance compared to the middle tertile. A 
pattern of poorer performance on emotion recognition both in those with higher and 
in those with lower genetic risk compared to the middle tertile was not consistent with 
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the model that included quadratic terms (ST6), and nor was it robust when changing 
the cut-off for genetic risk to examine patters across quartiles or quintiles.  
3.6 Multivariate analysis  
 
There was little evidence to support an association between the genetic risk scores 
and cognitive outcomes at either the primary PT (p=0.116) or secondary PT 
(p=0.184) when examining all cognitive domain associations within a multivariate 
model to help address multiple testing.  
 
3.7 Shared and non-shared effects of BD-PRS and SZ-PRS on cognition  
 
In the unadjusted (univariable) models, evidence of association with performance IQ 
and processing speed was stronger for the SZ-PRS than for the BD-PRS, whereas 
that for executive function was stronger for the BD-PRS. After adjusting for the SZ-
PRS in the multivariable model, effect sizes for the association between the BD-PRS 
and performance IQ and processing speed weakened substantially, though the 
association with executive function remained relatively unchanged (Table 1).  
 
Following the principal components analysis of the BD-PRS and SZ-PRS, we found 
strong evidence of association between the shared component and performance IQ 
(ß = -0.03, 95%CI -0.06, -0.01; p=0.004), processing speed (ß = -0.04, 95%CI -0.06, 
-0.01; p = 0.001), and more weakly with executive function (ß = -0.03, 95%CI -0.04, 
0.00; p=0.027), but little evidence of association between the difference component 
and these measures (Table 2). 
 
Finally, there was strong evidence of association between the SZvsBD PRS and 
performance IQ (ß= -0.03, 95%CI -0.06, -0.01; p=0.009), but no evidence of 
association with processing speed or executive function (both p>0.499) (Table 1).  
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4. Discussion  
 
4.1 Summary of findings 
 
Using a large population-based cohort study, we found consistent evidence that 
higher genetic risk for BD in healthy children from the general population at age 8 
years was associated with impaired executive functioning, and more weakly with 
poorer performance IQ and poorer processing speed. However, there was no or little 
evidence of association with verbal IQ, attention, working memory, verbal learning or 
social cognition. The associations between genetic risk for bipolar disorderBD and 
both performance IQ and processing speed seem to be primarily due to the genetic 
component that is shared with that for schizophrenia SZ risk, rather than genetic 
effects that differ across these disorders. However, executive functioning deficits 
appear to be associated with risk alleles for BD that are not shared with 
schizophreniaSZ.    
  
4.2 Interpreting findings in the context of previous work 
 
Epidemiological studies examining associations between cognition and BD suggest 
that cognitive deficits occur in between 40-60% of adults with BD (Bora, 2018; 
Szmulewicz et al., 2015). Whilst the cognitive deficits in adults with BD compared to 
adults with schizophrenia SZ are qualitatively similar, the severity of these deficits is 
typically less in those with BD (Bortolato et al., 2015). Nevertheless, these deficits 
are still of importance as they contribute to the level of functional impairment and 
impact on quality of life for individuals with BD (Bora, 2016).  
 
Our results for IQ implicate effects of genetic risk for BD on fluid but not crystalised 
intelligence, a finding similar to that in schizophrenia SZ (Hubbard et al., 2016). Our 
findings also suggest that genetic effects of BD on fluid intelligence is driven by risk 
SNPs that are shared between the BD-PRS and SZ-PRS. with a substantially 
greater proportion of the variance in PIQ explained by such shared SNPs or SNPs 
that are specific to schizophreniaSZ, rather than ones that have risk effects 
specifically on BD. This is consistent with the observation that IQ deficits are greater 
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in adults with schizophrenia SZ compared to adults with BD (Bora and Ozerdem, 
2017), and that it is the severity rather than the profile of cognitive deficits that 
differentiates these two disorders in adulthood (Vöhringer et al., 2013). Furthermore, 
greater severity of IQ deficits in people with BD has been linked to the presence of 
psychotic symptoms (McCarthy et al., 2016; Tsitsipa and Fountoulakis, 2015), whilst 
individuals with BD who had a manic psychosis had higher SZ-PRS scores 
compared to those with BD and no history of psychosis (Markota et al., 2018). These 
studies, in conjunction with our findings, suggest that both cognitive deficits and 
presence of psychotic phenomena in people with BD are primarily driven by risk 
SNPs that are shared across BD and schizophreniaSZ.   
 
We previously reported that higher IQ was associated with greater hypomania 
features, assessed using the Hypomania Checklist-32 (HCL-32), in young adults in 
the ALSPAC cohort (Smith et al., 2015). This does not appear to be consistent with 
our findings for BD genetic risk in this study. It is possible that hypomanic features, 
as captured by measures such as the HCL-32 in community samples, do not 
accurately index individuals with high propensity to develop BD. Consistent with this 
thesis, we found little evidence that the BD-PRS was associated with hypomania 
scores in ALSPAC, although there was some evidence of association with binary 
measures of hypomania when these were defined by cut-offs at higher extremes of 
the score (Mistry et al., 2018).   
 
The BD-PRS was more strongly associated with executive function than the SZ-PRS 
was in our study, and this didn’t change when adjusting for the SZ-PRS. Executive 
functioning is often used as a general umbrella term that captures 3 core domains: 
response inhibition, interference control, and cognitive flexibility (Diamond, 2013). 
Meta-analyses from systematic reviews show medium to large effect size deficits in 
executive functioning in both schizophreniaSZ (Fioravanti et al., 2012) and BD cases 
(Torres et al., 2007) as well as their first-degree relatives (Bortolato et al., 2015). The 
strongest evidence of deficits in executive functioning in people with 
schizophreniaSZ described in that review was within the domain of cognitive 
flexibility, whereas the review of BD described deficits across all 3 domains. As the 
Opposite World’s task that we used to assess executive functioning in our study 
primarily assesses response inhibition, this might explain why we observed a 
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stronger association with the BD-PRS than the SZ-PRS. Whilst deficits in different 
aspects of executive functioning might be more strongly related to genetic risk for BD 
than for schizophreniaSZ (or vice versa), and one study reported a BD-specific 
association with response inhibition compared to other psychotic disorders (Ethridge 
et al., 2014), deficits in response inhibition have also been described in people with 
schizophreniaSZ (Ettinger et al., 2018).  
 
We found some evidence of association between the BD-PRS and poorer 
processing speed, which was stronger at the less stringent PT. Moreover, when 
examining associations whilst adjusting for the SZ-PRS, associations attenuated 
substantially. Processing speed is often reported as one of the most impaired 
domains in adults with BD, evidenced by large effect size from meta-analysis (Bora, 
2018; Bora et al., 2009), and evidence in young people at high familial risk of BD 
(Bora et al., 2017). In our study, children within the general population at high 
genetic risk for BD do not appear to be as impaired in this cognitive domain as they 
are in executive functioning. It is possible however, that deficits in processing speed 
develop at a later time point compared to executive functioning as maturation of 
different cognitive processes can occur at different stages of development (Kail, 
1991; Luna et al., 2004).  
  
A previous study in the ALSPAC sample, but using the smaller PGC-1-BD GWAS to 
derive the PRS, also found no evidence of association between the BD-PRS and 
emotion recognition (Coleman et al., 2017). Our results, using a more powerful BD-
PRS, similarly provides little evidence for such a relationship. It is possible that other 
neurocognitive domains mature at an earlier time point in development, and that in 
general, social cognition measures develop at a later time point (Chronaki et al., 
2015). It is possible therefore that deficits in relation to genetic risk for BD become 
manifest only later in adolescent or early adult development. Furthermore, whilst 
deficits in social cognition more broadly are reported in the literature in adults with 
BD, deficits may be more pronounced for Theory of Mind rather than emotion 
recognition, which was the only measure of social cognition that we were able to 
examine here (Mitchell and Young, 2016).    
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4.3 Strengths and limitations 
 
This study has a number of strengths. Firstly, we have used the most recent and 
largest BD GWAS (Stahl et al., 2017) and the most recent SZvsBD GWAS (Ruderfer 
et al., 2018) as training sets from which to derive the PRSs, thus maximising power 
and minimising measurement error (Dudbridge, 2013). Second, we have used a 
large, well characterized general population-based sample for analyzing 
neurocognitive phenotypes at an early age, well before onset of BD. This means we 
can be confident the associations are not biased by presence of cognitive deficits 
arising as a result of BD or treatment effects. Third, we used well validated measures 
for assessing our neurocognitive phenotypes, reducing information bias in our 
results.  
 
However, there are also several limitations. Firstly, as with any longitudinal study, 
there was a large degree of attrition which might have led to selection bias. A 
previous study reported that genetic risk for schizophreniaSZ was associated with 
non-participation by both mothers and children in the ALSPAC sample (Martin et al., 
2016), whilst lower cognitive ability is also associated with greater attrition in 
ALSPAC (Boyd et al., 2013). We cannot rule out the possibility therefore of selection 
bias affecting the validity of our results, although such attrition generally has a 
minimal impact on estimates of association in contrast to estimates of prevalence 
(Wolke et al., 2009).  
 
Second, we were unable to examine all aspects of cognitive function due to the lack 
of availability of some measures in the ALSPAC sample, although we nevertheless 
assessed multiple cognitive domains that provided a reasonably comprehensive 
coverage of cognitive function.  
 
Third, the PRS approach captures information from common variants conferring risk 
for BD, but does not capture the effects of rare variants. This means our results only 
reflect common variant influences on childhood neurocognitive outcomes rather than 
the effects of all genetic risk.  
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Fourth, the assessment of multiple cognitive domain outcomes may lead to an 
increase in type I error. Whilst the cognitive domains we examined were selected a 
priori based on prior literature, the strength of evidence of the associations we report 
should be interpreted in the context of the study limitations, including the testing of 
multiple cognitive outcomes. In our multivariate analysis there was little evidence to 
support an association between genetic risk scores and cognitive outcomes, and 
replication of our findings in other large population-based samples is required.  
 
Fifth, we did not have data on whether parents of the participants had bipolar 
disorder. However, given the low lifetime risk of bipolar disorder it seems unlikely 
that this would have had any significant impact on our results. 
 
Finally, as the BD-PRS only explains a small proportion of variance in BD, the lack of 
evidence of association we observed for some cognitive measures might result from 
our analyses being under-powered to detect smaller effect sizes, despite our use of 
the largest BD GWAS to date to derive the genetic risk score. 
 
4.4 Implications  
 
We believe this work has several implications. The severity of deficits in cognitive 
domains of performance IQ and processing speed are similar to those observed in 
children at high genetic risk for schizophreniaSZ in the general population (Hubbard 
et al., 2016). Our evidence of cognitive deficits in genetically higher risk children in 
the general population supports other evidence suggesting that BD, like 
schizophreniaSZ, should also be considered as being on the neurodevelopmental 
spectrum (Fioravanti et al., 2012), and this is particularly so for more severe forms of 
BD characterized by psychotic symptoms in childhood (Arango et al., 2014).  
 
Overall, our findings are more consistent with epidemiological studies that have 
reported an increased risk of BD in those with lower cognitive ability in childhood  
(Meyer et al., 2004; Sharma et al., 2017) than studies reporting increased BD risk in 
those with higher cognitive ability (Gale et al., 2013; MacCabe et al., 2010). 
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Nevertheless, there is some evidence that risk alleles for BD may include both 
alleles that increase, and some that decrease, cognitive ability (Smeland et al., 
2019). This could lead to low levels of genetic correlation between BD and cognition 
and hence less consistent evidence of association between BD genetic risk and 
cognition compared to schizophreniaSZ genetic risk, as well as less consistent 
evidence of association between childhood cognition and BD compared to that for 
schizophreniaSZ.  
 
4.5 Conclusions  
 
Within this study of children from a prospective population-based birth cohort, we 
found associations between increased genetic risk for BD and poorer executive 
functioning, performance IQ and processing speed, but less consistent/no evidence 
of association with other cognitive domains. Our results for performance IQ and 
processing speed suggest that these associations appear to be driven primarily by 
genetic risk that is shared between BD and schizophreniaSZ, and those for 
executive functioning driven primarily by genetic risk that is independent of 
schizophreniaSZ. Nevertheless, using the largest GWAS to derive our polygenic risk 
scores still explains little of the variance in these cognitive phenotypes.  
 
Further work using both population-based longitudinal studies and clinical samples 
are required to determine the cognitive profiles of those at high genetic risk of BD, to 
inform studies of prediction, improve detection, and facilitate early intervention where 
appropriate. 
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